GeneSoft Licenses Rights to Factive from LG Life Sciences
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 30 (Table of Contents)
Published: 2 Nov-2002
DOI: 10.3833/pdr.v2002.i30.977 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GeneSoft and LG Life Sciences entered into a licensing agreement for LG’s quinolone antibiotic, Factive® (Gemifloxacin mesylate) for the treatment of bacterial infections...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS